Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) Study: Initial Report of Treatment and Outcomes

122. Cryptococcus Infection Network in Non-Human Immunodeficiency Virus Cohort (CINCH) Study: Initial Report of Treatment and Outcomes Andrej Spec, MD; Anil Panackal, MD, ScM, FIDSA; Peter Williamson, MD, PhD, Chief; John E. Bennett, MD; Julia Garcia-Diaz, MD, FIDSA; Darin Ostrander, PhD; Chiung-Yu Huang, PhD; Yifei Sun, PhD; Kieren A. Marr, MD, FIDSA; Infectious Disease, Washington University, St. Louis, Missouri; Staff Clinician, Translational Mycology Unit, Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; Translational Mycology Unit, Laboratory of Clinical Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland; Clinical Mycology Section, National Institute of Allergy and Infectious Diseases/National Institutes of Health, Bethesda, Maryland; Infectious Diseases, Ochsner Clinic Foundation, New Orleans, Louisiana; Johns Hopkins Hospital, Baltimore, Maryland; Division of Biostatistics and Bioinformatics Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University, Baltimore, Maryland; Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland; Medicine and Oncology, Johns Hopkins Hospital, Baltimore, Maryland; and CINCH Cohort Study Group and the MSGERC